Your browser doesn't support javascript.
COVID-19 re-infection in Shahroud, Iran: a follow-up study.
Zare, Fariba; Teimouri, Maryam; Khosravi, Ahmad; Rohani-Rasaf, Marzieh; Chaman, Reza; Hosseinzadeh, Ali; Jamali Atergeleh, Hozhabr; Binesh, Ehsan; Emamian, Mohammad Hassan.
  • Zare F; Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Teimouri M; Department of Biochemistry, School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Khosravi A; Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Rohani-Rasaf M; Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Chaman R; Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Hosseinzadeh A; Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Jamali Atergeleh H; Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Binesh E; Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Emamian MH; Ophthalmic Epidemiology Research Center, Shahroud University of Medical Sciences, Shahroud, Iran.
Epidemiol Infect ; 149: e159, 2021 04 19.
Article in English | MEDLINE | ID: covidwho-1301131
ABSTRACT
Although many people became infected and recovered during the COVID-19 epidemic, the immunity duration and re-infection in recovered patients have recently attracted many researchers. The aim of this study was to evaluate the recurrence of the infection in recovered individuals over a 9-month period after the onset of the COVID-19 epidemic. In this study, data related to COVID-19 patients in Shahroud city were collected using the electronic system for registering suspicious patients and also by checking patients' hospital records. In this study, from 20 March 2020 to 20 November 2020 (9 months), a total of 8734 suspected patients with respiratory symptoms were observed and followed up. RT-PCR was positive for 4039 patients. During this period, out of the total number of positive cases of COVID-19, 10 cases became re-infected after complete recovery. The risk of re-infection was 2.5 per thousand (0.95 CI 1.2-4.5). The mean time interval between the first infection and re-infection was 134.4 ± 64.5 days (range 41-234 days). The risk of re-infection between male and females was not statistically different (1.98 per 1000 women and 2.96 per 1000 men). Exposure to COVID-19 may not establish long-term protective immunity to all patients and may predispose them to re-infection. This fact can be reminded that the use of masks, social distancing and other preventive measures are very important in recovered patients and should be emphasised especially in health care personnel who are more exposed to the virus.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Reinfection / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Epidemiol Infect Journal subject: Communicable Diseases / Epidemiology Year: 2021 Document Type: Article Affiliation country: S095026882100087X

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Reinfection / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Epidemiol Infect Journal subject: Communicable Diseases / Epidemiology Year: 2021 Document Type: Article Affiliation country: S095026882100087X